ETHCHLORVYNOL Drug Patent Profile
✉ Email this page to a colleague
When do Ethchlorvynol patents expire, and when can generic versions of Ethchlorvynol launch?
Ethchlorvynol is a drug marketed by Banner Pharmacaps and is included in one NDA.
The generic ingredient in ETHCHLORVYNOL is ethchlorvynol. There is one drug master file entry for this compound. Additional details are available on the ethchlorvynol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ETHCHLORVYNOL?
- What are the global sales for ETHCHLORVYNOL?
- What is Average Wholesale Price for ETHCHLORVYNOL?
Summary for ETHCHLORVYNOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,931 |
| DailyMed Link: | ETHCHLORVYNOL at DailyMed |
Recent Clinical Trials for ETHCHLORVYNOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for ETHCHLORVYNOL
Anatomical Therapeutic Chemical (ATC) Classes for ETHCHLORVYNOL
US Patents and Regulatory Information for ETHCHLORVYNOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Banner Pharmacaps | ETHCHLORVYNOL | ethchlorvynol | CAPSULE;ORAL | 084463-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Banner Pharmacaps | ETHCHLORVYNOL | ethchlorvynol | CAPSULE;ORAL | 084463-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Banner Pharmacaps | ETHCHLORVYNOL | ethchlorvynol | CAPSULE;ORAL | 084463-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
